Clinical significance of Th17 cells in kidney transplantation

키워드

참고문헌 (61)

1. Halloran PF, "Immunosuppressive drugs for kidney transplantation", N Engl J Med, 351, pp.2715~2729 (2004)[DOI]
2. Liu Z, "CD4(+) T-cell subsets in transplantation", Immunol Rev, 252, pp.183~191 (2013)[DOI]
3. Park H, "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17", Nat Immunol, 6, pp.1133~1141 (2005)[DOI]
4. Harrington LE, "Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages", Nat Immunol, 6, pp.1123~1132 (2005)[DOI]
5. Wynn TA, "T(H)-17: a giant step from T(H)1 and T(H)2", Nat Immunol, 6, pp.1069~1070 (2005)[DOI]
6. Loong CC, "Expression of interleukin-17 as a predictive parameter in acute renal allograft rejection", Transplant Proc, 32, pp.1773~ (2000)[DOI]
7. Hsieh HG, "IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection", Transpl Int, 14, pp.287~298 (2001)[DOI]
8. Mitchell P, "The T helper 17-regulatory T cell axis in transplant rejection and tolerance", Curr Opin Organ Transplant, 14, pp.326~331 (2009)[DOI]
9. Calvo-Turrubiartes M, "Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level", Transpl Immunol, 21, pp.43~49 (2009)[DOI]
10. Warrens AN, "Pharmacological control of the immune response in renal transplantation", BJU Int, 90, pp.784~791 (2002)[DOI]
11. Crispim JC, "Interleukin-17 and kidney allograft outcome", Transplant Proc, 41, pp.1562~1564 (2009)[DOI]
12. Deteix C, "Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection", J Immunol, 184, pp.5344~5351 (2010)[DOI]
13. Loong CC, "Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection", J Pathol, 197, pp.322~332 (2002)[DOI]
14. Van Kooten C, "Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection", J Am Soc Nephrol, 9, pp.1526~1534 (1998)
15. Veldhoen M, "TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells", Immunity, 24, pp.179~189 (2006)[DOI]
16. Bettelli E, "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells", Nature, 441, pp.235~238 (2006)[DOI]
17. Ivanov II, "The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells", Cell, 126, pp.1121~1133 (2006)[DOI]
18. Kuchroo VK, "Emerging new roles of Th17 cells", Eur J Immunol, 42, pp.2211~2214 (2012)[DOI]
19. Van Voorhis M, "The aryl hydrocarbon receptor: a novel target for immunomodulation in organ transplantation", Transplantation, 95, pp.983~990 (2013)[DOI]
20. Singh SP, "Human T cells that are able to produce IL-17 express the chemokine receptor CCR6", J Immunol, 180, pp.214~221 (2008)[DOI]
21. Wilson NJ, "Development, cytokine profile and function of human interleukin 17-producing helper T cells", Nat Immunol, 8, pp.950~957 (2007)[DOI]
22. Merville P, "Cells infiltrating rejected human kidney allografts secrete IFN-gamma, IL-6, and IL-10, and are modulated by IL-2 and IL-4", Transplant Proc, 25(1), pp.111~113 (1993)
23. Merville P, "Detection of single cells secreting IFN-gamma, IL-6, and IL-10 in irreversibly rejected human kidney allografts, and their modulation by IL-2 and IL-4", Transplantation, 55, pp.639~646 (1993)[DOI]
24. Pavlakis M, "Intragraft IL-15 transcripts are increased in human renal allograft rejection", Transplantation, 62, pp.543~545 (1996)[DOI]
25. Solez K, "Banff 07 classification of renal allograft pathology: updates and future directions", Am J Transplant, 8, pp.753~760 (2008)[DOI]
26. 정병하, "Higher infiltration by Th17 cells compared with regulatory T cells is associated with severe acute T-cell-mediated graft rejection", Experimental and Molecular Medicine, 43(11), pp.630~637 (2011), 생화학분자생물학회
27. Stegall MD, "The role of complement in antibody-mediated rejection in kidney transplantation", Nat Rev Nephrol, 8, pp.670~678 (2012)[DOI]
28. Mauiyyedi S, "Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries", J Am Soc Nephrol, 12, pp.574~582 (2001)
29. Vanaudenaerde BM, "The role of interleukin-17 during acute rejection after lung transplantation", Eur Respir J, 27, pp.779~787 (2006)[DOI]
30. Healy DG, "Neutrophil transendothelial migration potential predicts rejection severity in human cardiac transplantation", Eur J Cardiothorac Surg, 29, pp.760~766 (2006)[DOI]
31. Gore-Hyer E, "TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells", Am J Physiol Renal Physiol, 283, pp.F707~F716 (2002)[DOI]
32. LeBleu VS, "Origin and function of myofibroblasts in kidney fibrosis", Nat Med, 19, pp.1047~1053 (2013)[DOI]
33. Chung BH, "Increase of Th17 cell phenotype in kidney transplant recipients with chronic allograft dysfunction", PLoS One, 10, pp.e0145258~ (2015)[DOI]
34. Chung BH, "Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients", Immunol Lett, 141, pp.181~189 (2012)[DOI]
35. Meier-Kriesche HU, "Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era", Am J Transplant, 4, pp.378~383 (2004)[DOI]
36. Guerra G, "Calcineurin inhibitor-free immunosuppression in kidney transplantation", Transpl Int, 20, pp.813~827 (2007)[DOI]
37. Rentenaar RJ, "Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo", Kidney Int, 62, pp.319~328 (2002)[DOI]
38. Takatsuki M, "Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance", Transpl Immunol, 8, pp.279~286 (2001)[DOI]
39. Weimer R, "Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses", Hum Immunol, 61, pp.884~897 (2000)[DOI]
40. Syrjala SO, "Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat", J Heart Lung Transplant, 29, pp.1047~1057 (2010)[DOI]
41. Chung BH, "Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression", PLoS One, 7, pp.e42011~ (2012)[DOI]
42. Chung BH, "Clinical significance of the ratio between FOXP3 positive regulatory T cell and interleukin-17 secreting cell in renal allograft biopsies with acute T-cell-mediated rejection", Immunology, 136, pp.344~351 (2012)[DOI]
43. Delgoffe GM, "The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2", Nat Immunol, 12, pp.295~303 (2011)
44. Zeiser R, "Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells", Blood, 111, pp.453~462 (2008)[DOI]
45. Flechner SM, "De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years", Am J Transplant, 4, pp.1776~1785 (2004)[DOI]
46. Larson TS, "Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus", Am J Transplant, 6, pp.514~522 (2006)[DOI]
47. Hackstein H, "Rapamycin and dendritic cells: keep on movin'", Transplantation, 82, pp.739~740 (2006)
48. Delgoffe GM, "The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment", Immunity, 30, pp.832~844 (2009)[DOI]
49. Chi H, "Regulation and function of mTOR signalling in T cell fate decisions", Nat Rev Immunol, 12, pp.325~338 (2012)[DOI]
50. Yurchenko E, "Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1", Th17 T effectors is abrogated by mTOR inhibition in vivo, 2012, pp.7, e35572~
51. Li Y, "CNI induced Th17", Treg imbalance and susceptibility to renal dysfunction in renal transplantation, 2011, pp.11, 2033~2038
52. Kim KW, "The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients", Immunology, 144, pp.68~78 (2015)[DOI]
53. Mora JR, "Vitamin effects on the immune system: vitamins A and D take centre stage", Nat Rev Immunol, 8, pp.685~698 (2008)[DOI]
54. Peelen E, "Effects of vitamin D on the peripheral adaptive immune system: a review", Autoimmun Rev, 10, pp.733~743 (2011)[DOI]
55. Baeke F, "Vitamin D: modulator of the immune system", Curr Opin Pharmacol, 10, pp.482~496 (2010)[DOI]
56. Smolders J, "Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis", J Steroid Biochem Mol Biol, 121, pp.243~246 (2010)[DOI]
57. Datta Mitra A, "<TEX>$1{\alpha}$<", TEX>,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT, J Invest Dermatol, pp.2013, 133[DOI]
58. Ranganathan P, "Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis", J Rheumatol, 40, pp.1529~1534 (2013)[DOI]
59. Lisse TS, "Vitamin D: a new player in the world of mTOR signaling", Cell Cycle, 10, pp.1888~1889 (2011)[DOI]
60. Lisse TS, "Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling", FASEB J, 25, pp.937~947 (2011)[DOI]
61. Chung BH, "Suppressive effect of <TEX>$1{\alpha}$<", TEX>,25-dihydroxyvitamin D3 on Th17-immune responses in kidney transplant recipients with tacrolimus-based immunosuppression, 2017, pp.101, 1711~1719

관련 논문AI추천